BioDelivery Sciences International (BDSI) Announces NDA Submission for BUNAVAIL on Track Following Positive Pre-NDA Meeting With FDA
6/10/2013 10:05:31 AM
More...
|
BioDelivery Sciences International (BDSI) to Present at the William Blair 33rd Annual Growth Stock Conference
6/5/2013 6:25:10 AM
More...
|
BioDelivery Sciences International (BDSI) to Present at the Jefferies and Co. 2013 Global Healthcare Conference
5/28/2013 7:10:15 AM
More...
|
BioDelivery Sciences International (BDSI) Provides Business Review and Update in Conjunction with Filing of First Quarter 2013 Financials
5/10/2013 6:56:41 AM
More...
|
BioDelivery Sciences International (BDSI) to Present at the Bank of America (BAC) Merrill Lynch 2013 Health Care Conference
5/7/2013 6:46:09 AM
More...
|
BioDelivery Sciences International (BDSI) Appoints Thomas W. D'Alonzo to Board of Directors
4/29/2013 7:00:57 AM
More...
|
BioDelivery Sciences International (BDSI) Pays Up to $40 Million for Pain Drug Candidate
3/26/2013 7:09:30 AM
More...
|
BioDelivery Sciences International (BDSI) Provides Business Review and Update in Conjunction With Filing of Its 2012 Annual Report
3/19/2013 9:35:09 AM
More...
|
BioDelivery Sciences International (BDSI) to Present at the 25th Annual ROTH Conference
3/13/2013 7:04:19 AM
More...
|
BioDelivery Sciences International (BDSI) to Present at the Cowen and Company 33rd Annual Health Care Conference
3/1/2013 7:51:02 AM
More...
|
|